Stoneridge Lifts Full-Year Guidance, Reports 7.9% Q1 Sales Growth
SRI sits 67% above its 52-week low of $4.19.
Summary
Stoneridge reported a 7.9% year-over-year rise in Q1 sales to $160.8 million and significantly raised its full-year revenue guidance by $20 million to $645-$670 million, also increasing its adjusted operating margin outlook. This positive earnings report directly contradicts a Reuters projection from April 24th that anticipated a substantial decrease in quarterly revenue and a loss. While an 8-K on April 28th hinted at strong Q1 sales, this news provides specific figures and, more importantly, updated forward-looking guidance. The improved outlook is attributed to manufacturing performance, growth in its MirrorEye system, and new contract manufacturing revenue, signaling a positive shift in the company's operational trajectory. Traders will be watching for continued execution on these improvements to sustain the revised guidance.
At the time of this announcement, SRI was trading at $7.00 on NYSE in the Manufacturing sector, with a market capitalization of approximately $199.3M. The 52-week trading range was $4.19 to $9.71. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Reuters.